Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Net Cash per Share : ₹3.87 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Vaidyane Ayurved Laboratories's Net Cash per Share for the quarter that ended in Mar. 2024 was ₹3.87.

The historical rank and industry rank for Vaidyane Ayurved Laboratories's Net Cash per Share or its related term are showing as below:

NSE:MADHAVBAUG' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 37.3 Med: 61.32 Max: 219.63
Current: 37.3

During the past 6 years, the highest Price-to-Net-Cash Ratio of Vaidyane Ayurved Laboratories was 219.63. The lowest was 37.30. And the median was 61.32.

NSE:MADHAVBAUG's Price-to-Net-Cash is ranked worse than
85.77% of 253 companies
in the Drug Manufacturers industry
Industry Median: 9.48 vs NSE:MADHAVBAUG: 37.30

Vaidyane Ayurved Laboratories Net Cash per Share Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Net Cash per Share Chart

Vaidyane Ayurved Laboratories Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Cash per Share

Get a 7-Day Free Trial

-18.86

-14.40

3.18

1.07

3.87

Vaidyane Ayurved Laboratories Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Net Cash per Share	Get a 7-Day Free Trial				3.18	-	1.07	5.34	3.87

Competitive Comparison of Vaidyane Ayurved Laboratories's Net Cash per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaidyane Ayurved Laboratories's Price-to-Net-Cash Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's Price-to-Net-Cash falls into.

Save Embed

;

Save Embed

;

Vaidyane Ayurved Laboratories Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Vaidyane Ayurved Laboratories's Net Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as

	Net Cash per Share (A: Mar. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(193.591	-	152.887	-	0.011)	/	10.513
=	3.87

Vaidyane Ayurved Laboratories's Net Cash per Share for the quarter that ended in Mar. 2024 is calculated as

	Net Cash per Share (Q: Mar. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(193.591	-	152.887	-	0.011)	/	10.513
=	3.87

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Vaidyane Ayurved Laboratories Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaidyane Ayurved Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Net Cash per Share

Traded in Other Exchanges

N/A

Address

201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604

Website

https://www.madhavbaug.org

Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines